Conference Coverage - Global Oncology Academy

Episodes 1-16 of 31

Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Global Oncology Academy
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
- Laura Cappelli, MD, MHS,MS
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Clinician's Roundtable
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
- Ihtisham Ahmad
From Diagnosis to Treatment: Challenges in Glioblastoma Care
From Diagnosis to Treatment: Challenges in Glioblastoma Care
NeuroFrontiers
From Diagnosis to Treatment: Challenges in Glioblastoma Care
- Lauren Schaff, MD
Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
Project Oncology®
Precision Strikes in Nuclear Medicine to Treat Prostate Cancer
- Munir Ghesani, MD
An Overview of the Fundamentals of PET-CT Imaging
An Overview of the Fundamentals of PET-CT Imaging
Project Oncology®
An Overview of the Fundamentals of PET-CT Imaging
Key Highlights from SNMMI 2024
Key Highlights from SNMMI 2024
Project Oncology®
Key Highlights from SNMMI 2024
Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC
Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC
Project Oncology®
Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC
- Geoffrey B. Johnson, M.D., Ph.D.
A Look at the Utility of PSMA PET Scans in Prostate Cancer
A Look at the Utility of PSMA PET Scans in Prostate Cancer
Project Oncology®
A Look at the Utility of PSMA PET Scans in Prostate Cancer
- Jennifer Caudle, DO
- Geoffrey B. Johnson, M.D., Ph.D.
The Evolving AI Landscape in Nuclear Medicine
The Evolving AI Landscape in Nuclear Medicine
Project Oncology®
The Evolving AI Landscape in Nuclear Medicine
- Joyita Dutta
Diving into New Directions of Radiopharmaceuticals
Diving into New Directions of Radiopharmaceuticals
Project Oncology®
Diving into New Directions of Radiopharmaceuticals
- Brianna Cagle
Highlighting the Current Status and Future of Theranostics
Highlighting the Current Status and Future of Theranostics
Project Oncology®
Highlighting the Current Status and Future of Theranostics
- Geoffrey B. Johnson, M.D., Ph.D.
A Unique Look at the Current and Future Directions of Cancer Vaccines
A Unique Look at the Current and Future Directions of Cancer Vaccines
Project Oncology®
A Unique Look at the Current and Future Directions of Cancer Vaccines
- Lillian Siu, MD, FRCPC
A Look at the Horizon of Cancer Vaccines
A Look at the Horizon of Cancer Vaccines
Project Oncology®
A Look at the Horizon of Cancer Vaccines
- Lillian Siu, MD, FRCPC
Updates on New Technologies and Imaging Agents in Healthcare
Updates on New Technologies and Imaging Agents in Healthcare
Project Oncology®
Updates on New Technologies and Imaging Agents in Healthcare
- Tyler J Bradshaw, PhD
ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
Project Oncology®
ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
- Jessica E. Hawley M.D. M.S.
Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
Project Oncology®
Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
- Neal Shore, MD

Prev
1
2
Next

1/2